Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Vein of Marshall Ethanol Infusion for Persistent Atrial Fibrillation (VOM-R01)

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2016 by The Methodist Hospital System
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
The Methodist Hospital System
Information provided by (Responsible Party):
Miguel X. Valderrabano, MD, The Methodist Hospital System Identifier:
First received: May 28, 2013
Last updated: September 13, 2016
Last verified: September 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2020
  Estimated Primary Completion Date: December 2019 (Final data collection date for primary outcome measure)